Uromitexan 200mg Injection 2ml

Cancer Oncology (448)Rx required

Key Information

Generic Name

Generic Name Mesna 200 mg

Manufacturer

Cadila Healthcare Ltd (Zydus)

Country of Origin

India

Detailed Information

Introduction

INTRODUCTION ABOUT UROMITEXAN 200MG INJECTIONUROMITEXAN 200MG INJECTION contains Mesna, which belongs to a group of medicines called Cytoprotective agents. UROMITEXAN 200MG INJECTION is used to protect the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine. UROMITEXAN 200MG INJECTION is also used to reduce the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals. UROMITEXAN 200MG INJECTION is not recommended for use in patients allergic to Mesna. Before receiving UROMITEXAN 200MG INJECTION, inform your doctor if you have liver problems (such as hepatic impairment), and/or kidney problems (such as renal impairment). UROMITEXAN 200MG INJECTION is generally not recommended for use during pregnancy and in women planning for pregnancy as it is not known whether the medicine can cause harm to the unborn baby. It is also not recommended for use in breastfeeding women. UROMITEXAN 200MG INJECTION should be used with caution in children and adolescents (aged below 18 years) only if necessary since it is not known whether the medicine is safe and effective in children. It is also advised to be used with caution in elderly patients (aged 65 years or older) after consulting the doctor. The most common

Uses

OF UROMITEXAN 200MG INJECTION Protects the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine Reduces the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals

How It Works

UROMITEXAN 200MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals.

Directions for Use

UROMITEXAN 200MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition.

Side Effects

taking UROMITEXAN 200MG INJECTION are headaches, dizziness, constipation, flu-like symptoms, sore throat, fever, cough, and/or diarrhea. Consult your doctor if any of these symptoms worsen. USES OF UROMITEXAN 200MG INJECTION Protects the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine Reduces the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals HOW UROMITEXAN 200MG INJECTION WORKSUROMITEXAN 200MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals. DIRECTIONS FOR USEUROMITEXAN 200MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition. SIDE EFFECTS OF UROMITEXAN 200MG INJECTIONCOMMON headaches dizziness, constipation, diarrhea flu, sore throat, cough Stop taking UROMITEXAN 200MG INJECTION and contact your doctor if you experience any of the following side effects: chest pain, rash, and/or itching

Warnings & Precautions

& PRECAUTIONSPREGNANCYMonitoring requiredUROMITEXAN 200MG INJECTION is generally not recommended for use during pregnancy unless it is clearly necessary. Consult your doctor before receiving the medicine. BREASTFEEDINGContraindicatedUROMITEXAN 200MG INJECTION is not recommended for use by breastfeeding women. Consult your doctor before receiving the medicine. DRIVING AND USING MACHINESUse with CautionDo not drive or operate machines if you experience syncope, light-headedness, lethargy, drowsiness, dizziness, and/or blurred vision after receiving UROMITEXAN 200MG INJECTION. KIDNEYUse with CautionUROMITEXAN 200MG INJECTION should be used with caution in patients with kidney problems, such as renal impairment. Consult your doctor before receiving the medicine. LIVERUse with CautionUROMITEXAN 200MG INJECTION should be used with caution in patients with liver problems such as hepatic impairment. Consult your doctor before receiving the medicine. ALLERGYContraindicatedDo not receive UROMITEXAN 200MG INJECTION if you are allergic (hypersensitive) to Mesna and/or any other ingredients of this medicine. USE IN PEDIATRICSConsult your doctorUROMITEXAN 200MG INJECTION should be used with caution in children and adolescents (aged below 18 years) only if necessary since it is not known whether the medicine is safe and effective in children. Consult your doctor before administering the medicine to the child. USE IN GERIATRICSUse with CautionUROMITEXAN 200MG INJECTION should be used with caution in elderly patients (aged 65 years or older). Consult your doctor before receiving the medicine. OTHERSBefore receiving UROMITEXAN 200MG INJECTION, inform your doctor if you: have any other medical conditions

Drug Interactions

SA. Drug-Drug interactions: Before receiving UROMITEXAN 200MG INJECTION, inform your doctor if you are taking any of the following medicines: oxazaphosphorine, cyclophosphamide, and ifosfamide (anticancer medicines) cytostatics (used to block the growth of cancer cells) Ex. adriamycin, methotrexate, and vincristine Overdosage: UROMITEXAN 200MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so you are unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms such as nausea, vomiting, abdominal pain, diarrhea, headache, fatigue, limb and joint pains, rash, flushing, low blood pressure, a slow or fast heart, paraesthesia (tingling or numbness in the legs or arms), fever, and/or bronchospasm. SYNOPSIS Drug : Mesna Pharmacological Category : Cytoprotective Agents Therapeutic Indication : Protects bladder and kidneys from cancer chemotherapy (Involving cyclophosphamide and ifosfamide), Reduces risk of bleeding from bladder (when Ifosfamide is used as a chemotherapy drug) Dosage Forms : Injection, Respirator Solution, Respules MORE INFORMATION Keep UROMITEXAN 200MG INJECTION out of reach of children Store UROMITEXAN 200MG INJECTION below 30°C

Frequently Asked Questions

Common questions and answers about Uromitexan 200mg Injection 2ml.

Q

What is UROMITEXAN 200MG INJECTION used for?

A

UROMITEXAN 200MG INJECTION is used to protect the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine. It is also used to reduce the risk of bleeding from the bladder when ifosfamide is used as a chemotherapy drug in affected individuals.

Q

What are the side effects of taking UROMITEXAN 200MG INJECTION?

A

The most common side effects of taking UROMITEXAN 200MG INJECTION are headaches, dizziness, constipation, flu-like symptoms, sore throat, fever, cough, and/or diarrhea. Consult your doctor if any of these symptoms worsen.

Q

How does UROMITEXAN 200MG INJECTION work?

A

UROMITEXAN 200MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals.

Q

How is UROMITEXAN 200MG INJECTION administered?

A

UROMITEXAN 200MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition.

Q

Can UROMITEXAN 200MG INJECTION be used for pregnant and breastfeeding women?

A

No, UROMITEXAN 200MG INJECTION is generally not recommended for use during pregnancy or in women planning for pregnancy since it is not known whether the medicine may cause harm to the unborn child. It is also not recommended for use by breastfeeding women. Consult your doctor before taking the medicine.

Article Information

DW

Written By

DETAILS Written By Dr. N. Sai Swaroop

Medical Content Writer

DS

Reviewed By

Dr. Sankara Babu Gorle

Medical Expert

Last Updated

17 Feb 2024

Tags

#cancer oncology (448)#generic name mesna 200 mg